Standard screening test: NONE

Alphafetoprotein, ultrasound, or CT scan can be used. These tests yield significant false positives and are not shown to reduce mortality.

  • The incidence of liver cancer increased significantly for males (2.3% per year) and females (2.4% per year).
  • These increases may be at least partially explained by rising immigration from regions of the world where risk factors for liver cancer, such as hepatitis B and C infection and exposure to aflatoxin, are more common.
  • Smoking, excess weight, physical inactivity, poor diet, alcohol consumption and infections continue to be important cancer prevention targets for the purpose of reducing incidence and disease-related costs.

Additional facts & information:

5 Year Survival

  • Stage 0 – no data
  • Stages 1&2 – 31%
  • Stage 3 – 11%
  • Stage 4 – 3%

About 45% of cases are diagnosed late at stage 3 or stage 4.